Enhanced therapeutic efficacy of tumor RNA-pulsed dendritic cells after genetic modification with lymphotactin

Human Gene Therapy

Volumn 10, Issue 7, 1999, Pages 1151-1161

  Zhang, Weiping ^a   He, Long ^a   Yuan, Zhenglong ^a   Xie, Zhifang ^a   Wang, Jianli ^a   Hamada, Hirofumi ^b   Cao, Xuetao ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b The Japan Foundation   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; LYMPHOTACTIN; MESSENGER RNA; TUMOR VACCINE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER IMMUNIZATION; CANCER SURVIVAL; CHEMOTAXIS; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; LUNG CARCINOMA; LUNG METASTASIS; MELANOMA B16; MOUSE; NONHUMAN; TUMOR CELL; TUMOR MODEL;

ADENOVIRIDAE; ANIMALS; BONE MARROW CELLS; CANCER VACCINES; CHEMOKINES, C; DENDRITIC CELLS; GENETIC VECTORS; HUMANS; LUNG NEOPLASMS; LYMPHOKINES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; RNA, MESSENGER; RNA, NEOPLASM; SIALOGLYCOPROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

ADENOVIRIDAE; ANIMALIA;

EID: 0033134826     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018148     Document Type: Article

References (45)

1. ADEMA, G.J., HARTGERS, F., VERSTRATEN, R., DE VRIES, E., MARLAND, G., MENON, S., FOSTER, J., XU, U., NOOYEN, P., McCLANHAN, T., BACON, K.B., and FIGDOR, C.G. (1997). A dendritic-cell-derived C-C chemokine that preferentially attracts naïve T cells. Nature (London) 387, 713-717.
2. AHUJA, S.S., MUMMIDI, S., MALECH, H.L., and AHUJA, S.K. (1998). Human dendritic cell (DC)-based anti-infective therapy: Engineering DCs to secrete functional IFN-gamma and IL-12. J. Immunol. 161(2), 868-876.
3. AICHER, A., WESTERMANN, J., CAYEUX, S., WILLIMSKY, G., DAEMEN, K., BLANKENSTEIN, T., UCKERT, W., DORKEN, B., and PEZZUTTO, A. (1997). Successful retroviral mediated transduction of a reporter gene in human dendritic cells: Feasibility of therapy with gene-modified antigen presenting cells. Exp. Hematol. 25, 39-44.
4. ARTHUR, J.F., BUTTERFIELD, L.H., ROTH, M.D., BUI, L.A., KIERTSCHER, S.M., LAU, R., DUBINETT, S., GLASPY, J., McBRIDE, W.H., and ECONOMOU, J.S. (1997). A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther. 4, 17-25.
5. ASHLEY, D.M., FAIOLA, B., NAIR, S., HALE, L.P., BIGNER, D.D., and GILBOA, E. (1997). Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. J. Exp. Med. 186, 1177-1182.
6. BANCHEREARU, J., and STEINMAN, R.M. (1998). Dendritic cells and the control of immunity. Nature (London) 392, 245-252.
7. BLOOM, M.B., PERRY-LALLEY, D., ROBBINS, P.F., LI, Y., ELGAMIL, M., ROSENBERG, S.A., and YANG, J.C. (1997). Identification of tyrosinase protein 2 as a tumor rejection antigen for the B16 melanoma. J. Exp. Med. 185, 453-459.
8. BOCZKOWSKI, D., NAIR, S.K., SNYDER, D., and GILBOA, E. (1996). Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med. 184, 465-472.
9. BOON, T., and VAN DER BROGGEN, P. (1996). Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183, 725-729.
10. BROSSART, P., GOLDRATH, A.W., BUTZ, E.A., MARTIN, S., and BEVAN, M.J. (1997). Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J. Immunol. 158, 3270-3276.
11. CAO, X., CHEN, G., ZHANG, W., TAO, Q., YU, Y., and YE, Y. (1996). Enhanced efficacy of combination of IL-2 gene and IL-6 gene-transfected tumor cells in the treatment of established metastatic tumors. Gene Ther. 3, 421-426.
12. CAO, X., ZHANG, W., HUANG, X., and WANG, J. (1997). Enhanced antitumor effects of tumor antigen-pulsed dendritic cells by their transfection with GM-CSF. Sci. China (Ser. C) 40, 539-545.
13. CAO, X., ZHANG, W., HE, L., XIE, Z., MA, S., TAO, Q., YU, Y., HAMADA, H., and WANG, J. (1998). Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity. J. Immunol. 161, 6238-6244.
14. CELLA, M., ENGERING, A., PINET, V., PIETERS, J., and LANZAVECCHIA, A. (1997). Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature (London) 388, 782-787.
15. CELLUZZI, C.M., MAYORDOMO, J.I., STORKUS, W.J., LOTZE, M.T., and FALO, L.D., JR. (1996). Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J. Exp. Med. 183, 283-287.
16. DIEU, M.C., VANBERVLIET, B., VICARI, A., BRIDON, J.M., OLDHAM, E., AIT-YAHIA, S., BRIERE, F., ZLOTNIKA, A., LEBECQUE, S., and CAUX, C. (1998). Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188, 373-386.
17. DILLOO, D., BACON, K., HOLEDEN, W., ZHONG, W., BURDACH, S., ZLOTNIK, A., and BRENNER, M. (1996). Combined chemokine and cytokine gene transfer enhances antitumor immunity. Nature Med. 2, 1090-1095.
18. FINN, O.J. (1993). Tumor-rejection antigens recognized by T lymphocytes. Curr. Opin. Immunol. 5, 701-708.
19. FIORETTI, F., FRADELIZI, D., STOPPACCIARO, A., RAMPONI, S., RUCO, L., MINTY, A., SOZZANI, S., GARLANDA, C., VECCHI, A., and MANTOVANI, A. (1998). Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer: perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor. J. Immunol. 161, 342-346.
20. GREAVES, D.R., WANG, W., DAIRAGHI, D.J., DIEU, M.C., DE SAINT-VIS, B., FRANZ-BACON, K., ROSSI, D., CAUX, C., MECLANAHAN, T., GORDON, S., ZLOTNIK, A., and SCHALL, T.J. (1997). CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3 alpha and is highly expressed in human dendritic cells. J. Exp. Med. 186, 837-844.
21. HEDRICK, J., SAYLOR, V., FIGUEROA, D., MIZOUE, L., XU, Y., MENON, S., ABRAMS, J., HANDEL, T., and ZLOTNIK, A. (1997). Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo. J. Immunol. 158, 1533-1540.
22. HSU, F.J., BENIKE, C., FAGNONI, F., LILES, T., CZERWINSKI, D., TAIDIL, B., ENGLEMAN, E.G., and LEVY, R. (1996). Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med. 2, 52-58.
23. KELNER, G.S., KENNEDY, J., BACON, K.B., KLEYENSTEUBER, S., LARGAESPADA, D.A.,. JENKINS, N.A., COPELAND, N.G., BAZAN, J.F., MOORE, K.W., SCHALL, T.J., and ZLOTNIK, A. (1994). Lymphotactin: A cytokine that represents a new class of chemokine. Science 266, 1395-1399.
24. KENNEDY, J., KELNER, G.S., KLEYENSTEUBER, S., SCHALL, T.J., WEISS, M.C., YSSEL, H., SCHNEIDER, P.V., COCKS, B.G., BACON, K.B., and ZLOTNIK, A. (1995). Molecular cloning and functional characterization of human lymphotactin. J. Immunol. 155, 203-209.
25. MALONE, R.W., FELGNER, P.L., and VERMA, I.M. (1989). Cationic liposome-mediated RNA transfection. Proc. Natl. Acad. Sci. U.S.A. 86, 6077-6081.
26. MANDELBOIM, O., BERKE, G., FRIDKIN, M., and FELDMAN, M., EISENSTEIN, M., and EISENBACH, L. (1994). CTL induction by a tumor-associated antigen octapeptide derived from a murine long carcinoma. Nature (London) 369, 67-71.
27. MAYORDOMO, J.I., ZORINA, T., STORKUS, W.J., ZITVOGEL, L., CELLUZZI, C., FALO, L.D., MELIEF, C.J., ILDSTAD, S.T., KAST, W.M., DELEO, A.B., and LOTZE, M.T. (1995). Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nature Med 1, 1297-1302.
28. MIYAKE, S., MAKIMURA, M., KANEGAE, Y., HARADA, S., SATO, Y., TAKAMORI, K., TOKUDA, C., and SAITO, I. (1996). Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. U.S.A. 93, 1320-1324.
29. MOHAMDZADEH, M., POLTORAK, N., BERGSTRESSER, P., BEUTLER, B., and TAKASHIMA, A. (1996). Dendritic cells produce macrophage inflammatory protein-1 gamma, a new member of the CC chemokine family. J. Immunol. 156, 3102-3106.
30. PAGLIA, P., CHIODONI, C., RODOLFO, M., and COLOMBO, M.P. (1996). Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 183, 317-322.
31. PORGADOR, A., and GILBOA, E. (1995). Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med. 182, 255-260.
32. POWER, C.A., CHURCH, D.J., MEYER, A., ALOUANI, S., PROUD-FOOT, A.E., CLARK-EWIS, I., SOZZANI, S., MANTOVANI, A., and WELLS, T.N.C. (1997). Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3 alpha from lung dendritic cells. J. Exp. Med. 186, 825-835.
33. REEVES, M.E., ROYAL, R.E., LAM, J.S., ROSENBERG, S.A., and HWU, P. (1996). Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res. 56, 5672-5677.
34. SCHULER, G., and STEINMAN, R.M. (1997). Dendritic cells as adjuvants for immune-mediated resistance to tumor. J. Exp. Med. 186, 1183-1187.
35. SONG, W., KONG, H., CARPENTER, H., TORII, H., GRANSTEIN, R., RAFII, S., MOORE, M.A.S., and CRYSTAL, R.G. (1997). Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model tumor antigen induce protective and therapeutic antitumor immunity. J. Exp. Med. 186, 1247-1256.
36. SOZZANI, S., LUINI, W., BORSATTI, A., POLENTARUTTI, N., ZHOU, D., PIEMONTI, L., AMICO, G.D., POWER, C.A., WELLS, T.N.C., GOBBI, M., ALLAVENA, P., and MANTOVANI, A. (1997). Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J. Immunol. 159, 1993-2000.
37. SOZZANI, S., ALLAVENA, P., D'AMICO, G., LUINI, W., BIANCHI, G., KATAURA, M., IMAI, T., YOSHIE, O., BONECCHI, R., and MANTOVANI, A. (1998). Differential regulation of chemokine receptors during dendritic cell maturation: A model for their trafficking properties. J. Immunol 161, 1083-1086.
38. SPECHT, J.M., WANG, G., DO, M.T., LAM, J.S., ROYAL, R.E., REEVES, M.E., ROSENBERG, S.A., and HWU, P. (1997). Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases. J. Exp. Med. 186, 1213-1221.
39. STEINMAN, R.M., PACK, M., and INABA, K. (1997). Dendritic cells in the T-cell areas of lymphoid organs. Immunol. Rev. 156, 25-37.
40. SZABOLCS, P., GALLARDO, H.F., CIOCON, D.H., SADELAIN, M., and YOUNG, J.W. (1997). Retrovirally transduced human dendritic cells express a normal phenotype and potent T-cell stimulatory capacity. Blood 90, 2160-2167.
41. TUTING, T., WILSON, C.C., MARTIN, D.M., KASAMON, Y.L., ROWLES, J., MA, D.I., SLINGLUFF, C.L., J.R., WAGNER, S.N., VAN DER BRUGGEN, P., BAAR, J., LOTZE, M.T., and STORKUS, W.J. (1998). Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: Enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha. J. Immunol. 160, 1139-1147.
42. WARD, S., BACON, K., and WESTWICK, J. (1998). Chemokines and T lymphocytes: More than an attraction. Immunity 9, 1-11.
43. YOSHIDA, T., IMAI, T., KAKIZAKI, M., NISHIMURA, M., TAKAGI, S., and YOSHIE, O. (1998). Identification of single C motif-1/lymphotactin receptor XCR1. J. Biol. Chem. 273, 16551-16554.
44. YOUNG, J.W., and INABA, K. (1996). Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity. J. Exp. Med. 183, 7-11.
45. ZHOU, L.J., and TEDDER, T.F. (1995). A distinct pattern of cytokine gene expression by human CD83(+) blood dendritic cells. Blood 86, 3295-3301.